www.24hreup.biz
Has www.24hreup.biz received an FDA warning letter about GLP-1 drugs?
Yes. FDA issued www.24hreup.biz a warning letter naming semaglutide, dated Apr 23, 2025, with the FDA subject line “Notice of Unlawful Sale of Unapproved Drugs to United States Consumers Over the Internet.”
FDA records in this index name www.24hreup.biz on Apr 23, 2025.
- Websites the letters name
- 24hreup.biz, 24hreup.com (see how each letter refers to them)
- Type named in FDA records
- Online seller
- FDA warning letters
- 1
- Drug recall reports
- 0
- Drugs named
- Semaglutide
- Latest record
- Apr 23, 2025
FDA warning letters
| Later letters FDA lists | Letter | |||
|---|---|---|---|---|
| Apr 23, 2025 | Notice of Unlawful Sale of Unapproved Drugs to United States Consumers Over the Internet | Semaglutide | None listed by FDA as of Nov 15, 2026 | fda.gov |
A warning letter states FDA’s view when it was issued; it is not a court finding, and the company may have responded since. The later-letters column repeats what FDA’s warning letter index lists for each letter.
FDA’s summary excerpts
- Apr 23, 2025: … into interstate commerce unapproved and misbranded semaglutide drug products. There are inherent risks to … and “Injectable” categories of your website, you offer semaglutide marketed as “Ozempic 0.5mg” packaged as “Оземпик … 1mg” packaged as “Оземпик 1,34 мг/мл,” and “Rybelsus Semaglutide 14mg” packaged as “1 blister card of 10 tablets.” … Full letter
Websites named in the letters
Each letter below is addressed to the firm FDA names in it, not to a website. The sentence quoted is the letter’s own reference to the site, copied from the letter on fda.gov.
- 24hreup.biz: FDA’s warning letter of Apr 23, 2025 is addressed to www.24hreup.biz. It refers to the site in these words: “… is to advise you that the United States (U.S.) Food and Drug Administration (FDA) recently reviewed your website at the Internet addresses www.24hreup.biz and has observed that your website introduces into interstate commerce misbranded and unapproved new drugs in violation of sections 301(a), …” Full letter
- 24hreup.com: FDA’s warning letter of Apr 23, 2025 is addressed to www.24hreup.biz. It refers to the site in these words: “We advise you to review your websites (including www.24hreup.com which forwards to www.24hreup.biz), product labels, and other labeling and promotional materials to ensure that you are not misleadingly …” Full letter
Drug recalls
No openFDA drug recall reports in this index.
This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.
Sources
Records last pulled Nov 15, 2026. Every entry links to the original public record.